The goal of this observational study is to learn about the effects of nazally applied exosome treatment on visual functions in children with Phase 1 Cerebral visual impairment (CVÄ°). The main question it aims to answer is: Does exosome therapy administered via the nasal route for neurological disorders in children with Phase 1 CVI also show a beneficial effect on visual functions? Researchers will compare visual and visual function findings before and after the exosome application to determine whether the exosome application is also effective in visual function. Participants: * They will receive exosomes via the nasal route every month for 6 months. * They will visit the clinic every month for monitoring and tests.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Whether exosome therapy combined with standardized neuro-visual rehabilitation improves functional vision outcomes compared to rehabilitation plus placebo.
Timeframe: Up to 1 year
Primary Objective ( Safety)
Timeframe: Up to 1 year
Affected Visual fields (Totally impaired /delayed)
Timeframe: Up to 1 year